Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection.

Some individuals in well-defined cohorts have now been infected with HIV-1 for well over a decade and yet remain clinically asymptomatic with normal CD4 counts. To determine immunologic and virologic parameters in these individuals, we examined 10 persons from the San Francisco City Clinic with firmly documented infection of 11-15 years duration who had maintained stable CD4 counts above 500 cells/microliters. Our results indicate that long-term nonprogressors are a heterogeneous group with respect to viral load and HIV-1-specific immune responses, and that progression can occur even after 15 years of stable infection. However, in a subset of persons with the lowest viral loads and persistent nonprogressive infection, we detected strong CTL responses, whereas neutralizing antibody studies revealed weak to undetectable titers against a panel of 10 primary isolates. This study demonstrates that a vigorous in vivo activated HIV-1-specific CTL response can be part of the host immune response in stable nonprogressive HIV-1 infection, and that circulating activated CTL can be detected in the setting of an extremely low viral load. These results also indicate that long-term nonprogressing HIV-1 infection does not require the presence of broadly cross-reactive neutralizing antibodies.

[1]  R. Colvin,et al.  Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens. , 1987, Journal of immunology.

[2]  G. Rutherford,et al.  A model-based estimate of the mean incubation period for AIDS in homosexual men. , 1988, Science.

[3]  D. Ho,et al.  Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. , 1989, The New England journal of medicine.

[4]  R. Young,et al.  Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Nixon,et al.  High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. , 1990, International immunology.

[6]  M. Salimans,et al.  Rapid and simple method for purification of nucleic acids , 1990, Journal of clinical microbiology.

[7]  B. Walker,et al.  HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. , 1991, Journal of immunology.

[8]  R. Koup,et al.  Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities , 1991, The Journal of experimental medicine.

[9]  J. Kaldor,et al.  Long-term symptomless HIV-1 infection in recipients of blood products from a single donor , 1992, The Lancet.

[10]  B. Walker,et al.  Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. , 1992, Journal of immunology.

[11]  R M Zinkernagel,et al.  Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells. , 1993, Journal of immunology.

[12]  R. Siliciano,et al.  A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes. , 1994, AIDS research and human retroviruses.

[13]  B. Walker,et al.  Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire , 1994, The Journal of experimental medicine.

[14]  R. Dewar,et al.  Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. , 1994, The Journal of infectious diseases.

[15]  J. Lieberman,et al.  Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor. , 1994, AIDS research and human retroviruses.

[16]  T. Greenough,et al.  Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. , 1994, AIDS research and human retroviruses.

[17]  R. Zinkernagel,et al.  T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. , 1994, Immunology today.

[18]  S. Buchbinder,et al.  Long‐term HIV‐1 infection without immunologic progression , 1994, AIDS.

[19]  J. Sninsky,et al.  Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection , 1994, Journal of clinical microbiology.

[20]  M. Hirsch,et al.  Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type 1-infected persons in the presence of combination antiretroviral agents. , 1995, The Journal of infectious diseases.

[21]  Martin A. Nowak,et al.  Antigenic oscillations and shifting immunodominance in HIV-1 infections , 1995, Nature.

[22]  John L. Sullivan,et al.  Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection , 1995 .

[23]  H. Schuitemaker,et al.  Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics , 1995, The Journal of experimental medicine.

[24]  J. Margolick,et al.  Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. , 1995, The New England journal of medicine.

[25]  R. Detels,et al.  Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity. , 1995, The Journal of infectious diseases.

[26]  R. Zinkernagel,et al.  Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus , 1995, Journal of virology.

[27]  D. Ho,et al.  Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. , 1995, The New England journal of medicine.

[28]  P. Borrow,et al.  Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression , 1995, Journal of virology.

[29]  C. Rinaldo,et al.  High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors , 1995, Journal of virology.